Advancements in Lupus Treatment Trials

This chapter explores the progress in Lupus treatment trials, focusing on the efficacy of targeting the immune system with biologics, particularly type 1 interferon blockers. It emphasizes the significance of specific endpoint criteria and collaborative efforts to redefine clinical outcomes for accelerating drug approval processes in Lupus treatment.